AI assistant
ARS Pharmaceuticals, Inc. — Director's Dealing 2024
Dec 5, 2024
32159_dirs_2024-12-04_5137beb3-f5ac-42a5-90b7-cb8da705fc63.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2024-12-02
Reporting Person: Chakma Justin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-02 | Common Stock | M | 45000 | $0.84 | Acquired | 181380 | Direct |
| 2024-12-02 | Common Stock | S | 45000 | $13.6715 | Disposed | 136380 | Direct |
| 2024-12-03 | Common Stock | M | 3260 | $0.84 | Acquired | 139640 | Direct |
| 2024-12-03 | Common Stock | M | 41740 | $0.84 | Acquired | 181380 | Direct |
| 2024-12-03 | Common Stock | S | 45000 | $13.1867 | Disposed | 136380 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | Stock Option (Right to Buy) | $0.84 | M | 45000 | Disposed | 2029-12-16 | Common Stock (45000) | Direct |
| 2024-12-03 | Stock Option (Right to Buy) | $0.84 | M | 3260 | Disposed | 2029-12-16 | Common Stock (3260) | Direct |
| 2024-12-03 | Stock Option (Right to Buy) | $0.84 | M | 41740 | Disposed | 2029-07-04 | Common Stock (41740) | Direct |
Footnotes
F1: The weighted average sale price for the transaction reported was $13.6715, and the range of prices were between $13.324 and $14.035. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
F2: The weighted average sale price for the transaction reported was $13.1867, and the range of prices were between $13.00 and $13.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
F3: Immediately exercisable.